Erdafitinib and enfortumab vedotin in pretreated FGFR2/3-mutant bladder cancer Published 2024-01-29 Download video MP4 360p Recommendations 05:14 Erdafitinib demonstrates efficacy in intermediate-risk NMIBC with FGFR alterations 09:58 CMML/JMML 12:54 My Experience in the Beginning With FOLFOX and FOLFIRI Chemo 11:30 Who is a Good Candidate for PRRT (Peptide Receptor Radionuclide Therapy) with Jonathan Strosberg, MD 10:39 AC22 - Explore Signaling Pathways and Combination Therapy in FGFR2-activated Cholangiocarcinoma 01:26 [68Ga]Ga-DPI-4452, a novel CA IX-targeting peptide, in metastatic ccRCC 02:46 An update on emerging therapies for the treatment of polycythemia vera 14:06 Holly's story: My experience with MG treatments 15:33 Connected Health Systems | Tampa General Hospital + Palantir 02:01 FGFR Mutations 19:22 Tampa General Hospital | Accelerating An Analytics Program Around Palantir Foundry & AIP 02:38 Local doctor says coconut oil helps reduce symptoms of Alzheimer's disease 26:34 Couple share what life is like with dementia - video #2 04:49 ANR Treatment Testimonial: After 10 Years of Opioid Dependency, David is Now Free From Opioids 02:24 Differentiating Between Essential Tremor and Parkinson's Disease 07:37 Jordana Green Leukemia & Lymphoma Society Fundraising Video 01:04 Treatment for Extreme Nose Bleeds 08:49 ASCO 2024 Top 5 Melanoma & Immunotherapy Abstracts with Omid Hamid, MD 10:39 This Is Good News (Brain Tumor Results) 02:24 ASCO 2024 Top 5 Zanidatamab Phase 2 HER2+ Questions on Biliary Tract Cancer Similar videos 46:19 Targeting FGFR in urothelial carcinoma 1:14:45 Advancing Bladder Cancer Care With Novel Therapeutics 38:23 New Standards of Therapy for Advanced Urothelial Carcinoma - EMPIRE Urology Lecture Series 1:01:13 Personalizing Bladder Cancer Care in the Modern Therapeutic Era 2:06:48 OncoAlert Colloquium Day 5 (GU Cancer, OncoAlert, Year in FDA approvals picks) More results